Sanjiv Dhingra

3.5k total citations
110 papers, 2.8k citations indexed

About

Sanjiv Dhingra is a scholar working on Molecular Biology, Surgery and Materials Chemistry. According to data from OpenAlex, Sanjiv Dhingra has authored 110 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 29 papers in Surgery and 25 papers in Materials Chemistry. Recurrent topics in Sanjiv Dhingra's work include MXene and MAX Phase Materials (24 papers), Mesenchymal stem cell research (19 papers) and Graphene and Nanomaterials Applications (18 papers). Sanjiv Dhingra is often cited by papers focused on MXene and MAX Phase Materials (24 papers), Mesenchymal stem cell research (19 papers) and Graphene and Nanomaterials Applications (18 papers). Sanjiv Dhingra collaborates with scholars based in Canada, India and United States. Sanjiv Dhingra's co-authors include Pawan K. Singal, Weiang Yan, Alireza Rafieerad, Glen Lester Sequiera, Anita Sharma, Niketa Sareen, Mohinder Pal Bansal, Keshav Narayan Alagarsamy, Rakesh C. Arora and Ejlal Abu‐El‐Rub and has published in prestigious journals such as Circulation, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Sanjiv Dhingra

102 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjiv Dhingra Canada 31 834 579 515 492 472 110 2.8k
Caiwen Ou China 35 1.3k 1.5× 225 0.4× 302 0.6× 489 1.0× 528 1.1× 107 2.9k
Jinju Wang China 34 2.3k 2.8× 339 0.6× 321 0.6× 279 0.6× 260 0.6× 98 4.3k
Di Wang China 28 1.5k 1.8× 309 0.5× 275 0.5× 221 0.4× 319 0.7× 122 3.0k
Mahmood Khan United States 37 1.3k 1.5× 129 0.2× 742 1.4× 380 0.8× 793 1.7× 111 3.8k
Linlin Zhang China 29 765 0.9× 221 0.4× 188 0.4× 629 1.3× 201 0.4× 189 2.7k
Dong Woon Kim South Korea 32 1.6k 2.0× 171 0.3× 220 0.4× 206 0.4× 701 1.5× 279 4.8k
Sai Ma China 30 1.3k 1.6× 156 0.3× 281 0.5× 414 0.8× 460 1.0× 72 4.0k
Xiaomeng Wang China 32 1.1k 1.4× 137 0.2× 259 0.5× 295 0.6× 300 0.6× 127 3.1k
Wenying Wei China 28 796 1.0× 272 0.5× 472 0.9× 861 1.8× 361 0.8× 65 3.1k

Countries citing papers authored by Sanjiv Dhingra

Since Specialization
Citations

This map shows the geographic impact of Sanjiv Dhingra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjiv Dhingra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjiv Dhingra more than expected).

Fields of papers citing papers by Sanjiv Dhingra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjiv Dhingra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjiv Dhingra. The network helps show where Sanjiv Dhingra may publish in the future.

Co-authorship network of co-authors of Sanjiv Dhingra

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjiv Dhingra. A scholar is included among the top collaborators of Sanjiv Dhingra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjiv Dhingra. Sanjiv Dhingra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Mehak, et al.. (2025). Scientometric analysis of evolution in sex-specific MSC therapy for cardiovascular diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(6). 167878–167878. 1 indexed citations
2.
Alagarsamy, Keshav Narayan, Saravanan Sekaran, Laura Fusco, et al.. (2025). MXenes as emerging materials to repair electroactive tissues and organs. Bioactive Materials. 48. 583–608. 7 indexed citations
3.
Shah, Ashish H., Heather Armstrong, Aleisha Reimer, et al.. (2025). IMpact of therapY using coleSevelam treatment reducing bile acids in patients with fonTan cIrCulation (MYSTIC): Rationale and study design. American Heart Journal. 291. 81–88. 1 indexed citations
4.
Ceylan, Ahmet, Alireza Rafieerad, Cansu Gürcan, et al.. (2024). Spatial transcriptomics reveals the interplay between cancer and immune cells directed by MXene quantum dots. Nano Today. 56. 102285–102285. 8 indexed citations
5.
6.
7.
Sareen, Niketa, et al.. (2024). Reduced cyclooxygenase 2 levels after hypoxia exposure result in the loss of immunoprivilege of allogeneic mesenchymal stem cells. Vascular Pharmacology. 155. 107351–107351. 1 indexed citations
8.
Alagarsamy, Keshav Narayan, et al.. (2024). Synthesis of Hydrofluoric (HF) Acid Free, Two-Dimensional (2D) Tantalum Carbide MXene Nanosheets and Quantum Dots. Methods in molecular biology. 2835. 261–267. 1 indexed citations
9.
Dhingra, Rimpy, Inna Rabinovich-Nikitin, Hongying Gang, et al.. (2022). Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy. Circulation. 146(12). 934–954. 51 indexed citations
10.
Sequiera, Glen Lester, Abhay Srivastava, Niketa Sareen, et al.. (2022). Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Science Advances. 8(14). eabl4370–eabl4370. 17 indexed citations
11.
Srivastava, Abhay, et al.. (2022). Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient. Stem Cell Research. 64. 102891–102891. 1 indexed citations
12.
Srivastava, Abhay, Cheryl R. Greenberg, Niketa Sareen, Vincenzo Lionetti, & Sanjiv Dhingra. (2022). An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients. Molecular and Cellular Biochemistry. 477(6). 1681–1695. 15 indexed citations
13.
Ammar, Hania Ibrahim, Asmaa Mohammed ShamsEldeen, Hend Ashour, et al.. (2021). Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats. American Journal of Physiology-Heart and Circulatory Physiology. 320(4). H1290–H1302. 29 indexed citations
14.
Srivastava, Abhay, Keshav Narayan Alagarsamy, Glen Lester Sequiera, Cheryl R. Greenberg, & Sanjiv Dhingra. (2021). Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome. Stem Cell Research. 53. 102355–102355. 5 indexed citations
15.
Franchi, Federico, et al.. (2020). Abstract 16757: Immunomodulatory Hydrogel Promotes Survival of Mesenchymal Stem Cells in a Rat Model of Myocardial Infarction. Circulation. 142(Suppl_3). 2 indexed citations
16.
Bagchi, Ashim K., et al.. (2012). Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine. 61(1). 304–314. 21 indexed citations
17.
Dhingra, Sanjiv & Mohinder Pal Bansal. (2006). Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation. Chemico-Biological Interactions. 161(1). 49–56. 45 indexed citations
18.
Kaur, Kuljeet, Anita Sharma, Sanjiv Dhingra, & Pawan K. Singal. (2006). Interplay of TNF-α and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. Journal of Molecular and Cellular Cardiology. 41(6). 1023–1030. 104 indexed citations
19.
Dhingra, Sanjiv & Mohinder Pal Bansal. (2005). Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status. Lipids in Health and Disease. 4(1). 28–28. 29 indexed citations
20.
Dhingra, Sanjiv, et al.. (2004). Effect of Selenium Depletion and Supplementation on the Kinetics of Type I 5'-Iodothyronine Deiodinase and T<sub>3</sub>/T<sub>4</sub> in Rats. Biological Trace Element Research. 97(1). 95–104. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caiwen Ou Breakdown of academic impact, for papers by Jinju Wang Breakdown of academic impact, for papers by Di Wang Breakdown of academic impact, for papers by Mahmood Khan Breakdown of academic impact, for papers by Linlin Zhang Breakdown of academic impact, for papers by Dong Woon Kim Breakdown of academic impact, for papers by Sai Ma Breakdown of academic impact, for papers by Xiaomeng Wang Breakdown of academic impact, for papers by Wenying Wei
Rankless by CCL
2026